In order to provide a novel cancer treatment method using an FTD/TPI combination drug that exhibits an outstanding anti-tumor effect and has few side effects, the present invention provides an anti-tumor drug that is characterized in that an FTD/TPI combination drug and an anti-tumor platinum complex are administered in combination.